Viral Conjunctivitis Industry Pipeline Review H2 Global Research Report

By Author: Priyank Tiwari
Total Articles: 3
Comment this article

Viral Conjunctivitis - Pipeline Review, H2 2013 provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Viral Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Viral Conjunctivitis. Viral Conjunctivitis - Pipeline Review, Half Year is built using data and information sourced proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together.
Complete report is spread across 56 pages is available @ http://www.reportsnreports.com/reports/271751-viral-conjunctivitis-pipeline-review-h2-2013.html
Scope
• A snapshot of the global therapeutic scenario for Viral Conjunctivitis.
• A review of the Viral Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage ...
... of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Viral Conjunctivitis pipeline on the basis of route of administration and molecule type.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.
Reasons to buy
• Identify and understand important and diverse types of therapeutics under development for Viral Conjunctivitis.
• Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
• Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding Viral Conjunctivitis pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
List of Tables
• Number of Products Under Development for Viral Conjunctivitis, H2 2013
• Products under Development for Viral Conjunctivitis - Comparative Analysis, H2 2013
• Number of Products under Development by Companies, H2 2013
• Comparative Analysis by Mid Clinical Stage Development, H2 2013
• Comparative Analysis by Early Clinical Stage Development, H2 2013
• Comparative Analysis by Pre-Clinical Stage Development, H2 2013
• Products under Development by Companies, H2 2013
• NanoViricides, Inc., H2 2013
• NovaBay Pharmaceuticals, Inc., H2 2013
• Starpharma Holdings Limited, H2 2013
• Foresight Biotherapeutics, Inc., H2 2013
• Redox Pharmaceutical Corporation, H2 2013
• Assessment by Monotherapy Products, H2 2013
• Assessment by Stage and Route of Administration, H2 2013
• Assessment by Stage and Molecule Type, H2 2013
• Viral Conjunctivitis Therapeutics - Drug Profile Updates
• Viral Conjunctivitis Therapeutics - Dormant Products
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=271751.
List of Figures
• Number of Products under Development for Viral Conjunctivitis, H2 2013
• Products under Development for Viral Conjunctivitis - Comparative Analysis, H2 2013
• Products under Development by Companies, H2 2013
• Mid Clinical Stage Products, H2 2013
• Early Clinical Stage Products, H2 2013
• Pre-Clinical Stage Products, H2 2013
• Assessment by Monotherapy Products, H2 2013
• Assessment by Route of Administration, H2 2013
• Assessment by Stage and Route of Administration, H2 2013
• Assessment by Molecule Type, H2 2013
• Assessment by Stage and Molecule Type, H2 2013
About Us:
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need.